18th Jun 2020 18:26
(Alliance News) - Oxford Biomedica PLC on Thursday said it intends to raise up to GBP40 million to help exploit opportunities in the growing cell and gene therapy market.
The company said it would place up to 5.0 million shares, representing around 6.5% of the total shares in issue, at a placing price of 800 pence each. The stock closed down 2.1% at 829.00 pence on Thursday.
By Arvind Bhunjun; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Biomedica